0
0
Read Time:11 Second
Drugmaker Aurobindo Pharma’s formulation manufacturing facility (Unit III) in Hyderabad, which was in July issued a Form 483 with three observations by the U.S. Food and Drug Administration (FDA) after an inspection, has received an establishment…
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %